Simultaneous determination of clozapine, olanzapine, risperidone and quetiapine in plasma by high-performance liquid chromatography–electrospray ionization mass spectrometry
- 5 April 2004
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 802 (2) , 257-262
- https://doi.org/10.1016/j.jchromb.2003.11.037
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoringJournal of Chromatography B, 2003
- Correlation of Cytochrome P450 (CYP) 1A2 Activity Using Caffeine Phenotyping and Olanzapine Disposition in Healthy VolunteersNeuropsychopharmacology, 2002
- Direct‐injection high performance liquid chromatography ion trap mass spectrometry for the quantitative determination of olanzapine, clozapine and N‐desmethylclozapine in human plasmaRapid Communications in Mass Spectrometry, 2002
- Cytochrome P450 2D6 Deficiency and its Clinical Relevance in a Patient Treated with RisperidonePharmacopsychiatry, 2002
- Olanzapine: Pharmacology, Pharmacokinetics and Therapeutic Drug MonitoringFortschritte der Neurologie · Psychiatrie, 2001
- Possible Relationship between Combined Plasma Concentrations of Risperidone plus 9-Hydroxyrisperidone and Extrapyramidal SymptomsNeuropsychobiology, 2001
- Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients.Journal of Pharmaceutical and Biomedical Analysis, 2001
- Simultaneous determination of clozapine, norclozapine and clozapine‐N‐oxide in human plasma by high‐performance liquid chromatography with ultraviolet detectionBiomedical Chromatography, 2001
- Is Therapeutic Drug Monitoring a Case for Optimizing Clinical Outcome and Avoiding Interactions of the Selective Serotonin Reuptake Inhibitors?Therapeutic Drug Monitoring, 2000
- Determination of an antipsychotic agent (ICI 204,636) and its 7-hydroxy metabolite in human plasma by high-performance liquid chromatography and gas chromatography—mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1992